Increase in incidence of adult T-cell leukemia/lymphoma in non-endemic areas of Japan and the United States

被引:37
作者
Chihara, Dai [1 ,2 ]
Ito, Hidemi [1 ]
Katanoda, Kota [3 ]
Shibata, Akiko [3 ]
Matsuda, Tomohiro [3 ]
Tajima, Kazuo [1 ]
Sobue, Tomotaka [4 ]
Matsuo, Keitaro [1 ,2 ]
机构
[1] Aichi Canc Ctr, Res Inst, Div Epidemiol & Prevent, Nagoya, Aichi 464, Japan
[2] Nagoya Univ, Grad Sch Med, Dept Epidemiol, Nagoya, Aichi 4648601, Japan
[3] Natl Canc Ctr, Ctr Canc Control & Informat Serv, Surveillance Div, Tokyo 104, Japan
[4] Osaka Univ, Grad Sch Med, Dept Environm Med & Populat Sci, Osaka, Japan
关键词
VIRUS TYPE-I; LEUKEMIA-LYMPHOMA; POPULATION; INFECTION; CARRIERS; HTLV-1; RATES;
D O I
10.1111/j.1349-7006.2012.02373.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Adult T-cell leukemia/lymphoma (ATLL) is a peripheral T cell neoplasm that is associated with infection by the human T-cell leukemia virus type I (HTLV-1). Although the high incidence of ATLL in HTLV-1-endemic areas is well known, population-based evidence concerning the incidence of ATLL in non-endemic areas is scarce. To answer this, we estimated the age-standardized incidence of ATLL from 1993 to 2006 for Japan and 1993 to 2008 for the US and assessed its trend using data from a population-based cancer registry in Japan and Surveillance Epidemiology and End Results (SEER) in the US. The Japanese data were collected from 15 prefectures. A total of 2055 patients in the three prefectures in Kyushu and 1380 patients in the 12 prefectures in Honshu were diagnosed with ATLL in the study period. In the US, a total of 140 patients were diagnosed with ATLL. The results showed that the age-standardized incidence in non-endemic areas in Japan and in the US significantly increased during this period (annual percent change [95%CI]; Japan-Honshu: +4.6% [1.1, 8.2]; US: +6.2% [1.5, 11.1]), while in the endemic areas of Japan there was no change (annual percent change [95%CI]; Japan-Kyushu: 0.0% [-1.6, 1.7]). This result indicates that the disease has been spread by carriers to non-endemic areas, and suggests the necessity of establishing a standard preventive strategy.
引用
收藏
页码:1857 / 1860
页数:4
相关论文
共 20 条
[1]   Practical implications of imposing a new world standard population [J].
Bray, F ;
Guilloux, A ;
Sankila, R ;
Parkin, DM .
CANCER CAUSES & CONTROL, 2002, 13 (02) :175-182
[2]  
Curado M.P. E., 2007, Cancer Incidence in Five Continents, VIX
[3]   AN HTLV-I VACCINE - WHY, HOW, FOR WHOM [J].
DETHE, G ;
BOMFORD, R .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1993, 9 (05) :381-386
[4]  
Hino Shigeo, 1997, Leukemia (Basingstoke), V11, P57
[5]  
Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.3.CO
[6]  
2-Q
[7]   Cancer Incidence and Incidence Rates in Japan in 2005: Based on Data from 12 Population-based Cancer Registries in the Monitoring of Cancer Incidence in Japan (MCIJ) Project [J].
Matsuda, Tomohiro ;
Marugame, Tomomi ;
Kamo, Ken-ichi ;
Katanoda, Kota ;
Ajiki, Wakiko ;
Sobue, Tomotaka .
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (01) :139-147
[8]   THE EPIDEMIOLOGY OF HTLV-I INFECTION [J].
MUELLER, N .
CANCER CAUSES & CONTROL, 1991, 2 (01) :37-52
[9]  
National Cancer Institute DCCPS Surveillance Research Program, Surveillance, Epidemiology, and End Results (SEER) Program populations (1969-2018)
[10]   Pathological features of diseases associated with human T-cell leukemia virus type I [J].
Ohshima, Koichi .
CANCER SCIENCE, 2007, 98 (06) :772-778